New York Hosts 'Prescription for Progress' Adult-Use Cannabis Forum
State regulators and industry stakeholders convened to address New York's stalled adult-use rollout and licensing delays.

Vibrant red corner cafe in bustling New York City, capturing urban life.
Forum Targets Rollout Delays
The event brought together state regulators, operators, and advocates to diagnose why New York's adult-use market remains far behind original projections. Since the Marijuana Regulation and Taxation Act passed in March 2021, the state's struggled to issue retail licenses at scale. As of May 2026, fewer than 150 adult-use dispensaries operate statewide—a fraction of the 500-plus originally forecast by this date.
Three core issues dominated the agenda: expediting the Office of Cannabis Management's (OCM) conditional license reviews, addressing zoning conflicts that have blocked storefronts in key municipalities, and closing the enforcement gap on unlicensed shops. Stakeholders pressed OCM Director Chris Alexander on timelines for the next wave of retail licenses. He offered no firm dates.
Licensing Bottleneck Persists
New York's Conditional Adult-Use Retail Dispensary (CAURD) program, designed to prioritize justice-involved applicants, has issued approximately 140 licenses since late 2022. Conversion of those conditional licenses to full operational status has lagged. Roughly 60% of CAURD licensees remain pre-revenue, citing delays in final inspections, supply-chain constraints, and municipal pushback.
OCM's understaffing has created a multi-month queue for final sign-offs. Alexander acknowledged the backlog but didn't commit to a hard deadline for clearing the pipeline. The agency has added 12 compliance officers since January 2026, yet industry attorneys say the pace remains insufficient to meet pent-up demand.
Illicit Market Undercuts Legal Operators
Unlicensed storefronts continue to outnumber legal dispensaries in New York City by an estimated 3-to-1 margin. Operators at the forum described a two-tier enforcement reality: licensed retailers face strict packaging and testing requirements, while illegal shops operate openly with minimal consequence. The state's padlock authority, granted under the 2023 budget, has resulted in fewer than 50 closures to date.
The enforcement gap is the single largest barrier to profitability for compliant operators. Until the state moves faster on closures, legal stores can't compete on price.
OCM has signaled it'll ramp enforcement partnerships with local sheriffs and the New York City Sheriff's Office. No new funding was announced.
Zoning Conflicts Stall Retail Expansion
Municipal opt-outs and restrictive zoning ordinances have blocked retail applications in 40% of New York counties. While the MRTA prohibits outright bans, local governments retain zoning authority over location, setbacks, and density. Several suburban counties have imposed 1,000-foot buffer zones around schools and parks, effectively eliminating most commercial corridors.
Advocates called for state preemption language similar to California's AB 1356, which limits local zoning restrictions. No legislative proposal was introduced, but Assembly members present indicated interest in a 2027 session bill.
What Comes Next
OCM committed to publishing a revised licensing timeline by June 15, 2026, with monthly issuance targets through year-end. The agency also plans to launch a public dashboard tracking conditional-to-operational conversions—a transparency measure operators have requested since 2023. For full background on New York's adult-use program, see the CannIntel topic hub on New York Cannabis Rollout.
The forum produced no binding policy changes. Participants described it as the most direct dialogue with OCM leadership since the program's launch. The next signal: whether June's licensing data shows measurable acceleration or more of the same incremental pace that's defined the rollout to date.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
How many adult-use cannabis dispensaries are open in New York?
As of May 2026, fewer than 150 adult-use dispensaries operate statewide. This is significantly below the 500-plus locations originally projected by this point in the rollout.
What is the CAURD program in New York?
The Conditional Adult-Use Retail Dispensary program prioritizes justice-involved applicants for the first wave of retail licenses. Approximately 140 CAURD licenses have been issued since late 2022, but many remain pre-operational.
Why are so many unlicensed cannabis shops still open in New York?
Enforcement has been slow. The state's padlock authority has resulted in fewer than 50 closures to date. Unlicensed storefronts outnumber legal dispensaries roughly 3-to-1 in New York City, creating an uneven playing field.
When will New York issue more adult-use cannabis licenses?
The Office of Cannabis Management committed to publishing a revised licensing timeline by June 15, 2026, with monthly issuance targets through year-end. No specific numbers were announced at the forum.
Can local governments ban cannabis dispensaries in New York?
No. The MRTA prohibits outright bans, but municipalities retain zoning authority over location, setbacks, and density. Many counties have imposed restrictive buffer zones that effectively limit available sites.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Massachusetts Launches THC Potency Inflation Audits for Licensed Labs
The Cannabis Control Commission will audit testing labs for systematic THC inflation starting June 2026.

Alabama Delays Automatic Marijuana Rescheduling Following Federal Shift
State officials invoke emergency rulemaking to halt state-law trigger tied to DEA rescheduling.

Canadian Tribunal Upholds Cannabis Ban for Flight Attendants
Employment board affirms airline's right to prohibit off-duty cannabis use under federal safety regulations.
More from the newsroom

Genetic Pathways Link Cannabis Use Disorder and Psychosis Risk
New research identifies shared genetic mechanisms between cannabis dependence and psychotic disorders, adding molecular evidence to a decades-old debate.

Tilray US Cannabis Entry Faces Regulatory and Capital Hurdles
Despite CEO optimism, Tilray Brands confronts Schedule III barriers, 280E tax penalties, and stretched balance sheet before any US THC play.

Jamaica Merges Ganja and Psilocybin Tourism in New Wellness Offerings
Resorts and herbalists now pair cannabis, psilocybin mushrooms, and steam-chalice rituals in legal wellness packages targeting international travelers.